1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America Asthma Drugs Market – By Medication

1.3.2        South and Central America Asthma Drugs Market – By Route of Administration

1.3.3        South and Central America Asthma Drugs Market – By Distribution Channel

1.3.4        South and Central America Asthma Drugs Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Asthma Drugs Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South and Central America– PEST Analysis

4.3         Expert Opinion

5.           Asthma Drugs Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Environmental Implications & Genetic Implications of Air Pollution

5.1.2        More Vulnerability in Specific Ethnic Groups

5.1.3

5.1.4        Growing Prevalence of Physiological Disorders Harboring Asthma

5.2         Market Restraints

5.2.1        Unmet Medical Needs

5.3         Market Opportunities

5.3.1        Opportunities with Commercialization of Biologics

5.4         Future Trends

5.4.1        Increasing Research Activities and Product Innovations

5.5         Impact Analysis

6.           Asthma Drugs Market– South and Central America Analysis

6.1         South and Central America Asthma Drugs Market Revenue Forecast and Analysis

7.           Asthma Drugs Market Analysis – by Medication

7.1         Overview

7.2         Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

7.3         Quick Relief Medications

7.3.1        Overview

7.3.2        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Long-term Control Medications

7.4.1        Overview

7.4.2        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asthma Drugs Market Analysis – By Route of Administration

8.1         Overview

8.2         Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)

8.3         Inhaled

8.3.1        Overview

8.3.2        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.4         Prefilled Syringe/Vials

8.4.1        Overview

8.4.2        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.5         Others (Oral, Nasal, Ophthalmic Etc.)

8.5.1        Overview

8.5.2        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.           Asthma Drugs Market Analysis – By Distribution Channel

9.1         Overview

9.2         Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)

9.3         Online Pharmacies

9.3.1        Overview

9.3.2        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.5         Retail Pharmacies and Drugstores

9.5.1        Overview

9.5.2        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

10.        Asthma Drugs Market – South and Central America Analysis

10.1      South and Central America: Asthma Drugs Market Revenue and Forecast to 2028

10.1.1     Overview

10.1.2     South and Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.3     South and Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.4     South and Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.5     South and Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6     South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

10.1.6.1       Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1       Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2       Brazil: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.1.3       Brazil: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.1.4       Brazil: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.2       Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1       Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2       Argentina: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.2.3       Argentina: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.2.4       Argentina: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.3       Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1       Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2       Rest of South & Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.3.3       Rest of South & Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.3.4       Rest of South & Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Asthma Drugs Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      GlaxoSmithKline plc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Boehringer Ingelheim International GmbH

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Merck & Co., Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips N.V.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Sanofi

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Pfizer Inc. (Arena Pharmaceutical GmbH)

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Novartis AG

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Abbott

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Common SABAs

Table 2.             Commonly inhaled corticosteroids

Table 3.             South and Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 4.             South and Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 5.             South and Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 11.          Argentina: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of South & Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of South & Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of South & Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 15.          Organic Developments in the Asthma Drugs Market

Table 16.          Inorganic Developments in the Asthma Drugs Market

Table 17.          Glossary of Terms, Asthma Drugs Market

LIST OF FIGURES

Figure 1.           Asthma Drugs Market Segmentation

Figure 2.           Asthma Drugs Market, By Country

Figure 3.           South and Central America Asthma Drugs Market Overview

Figure 4.           The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market

Figure 6.           South and Central America Asthma Drugs Market- Leading Country Markets (US$ Million)

Figure 7.           South and Central America PEST Analysis

Figure 8.           Expert Opinion

Figure 9.           Impact of Low Mood/Anxiety on Asthma

Figure 10.        Asthma Drugs Market Impact Analysis of Drivers and Restraints

Figure 11.        South and Central America Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028

Figure 12.        Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

Figure 13.        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)

Figure 16.        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 17.        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 18.        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 19.        Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)

Figure 20.        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 21.        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 22.        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 23.        South and Central America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        South and Central America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 25.        South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)

Figure 26.        Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)